Valley Wealth Managers’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-21
Closed -$425 347
2023
Q3
$425 Hold
21
﹤0.01% 343
2023
Q2
$537 Hold
21
﹤0.01% 315
2023
Q1
$625 Hold
21
﹤0.01% 330
2022
Q4
$568 Hold
21
﹤0.01% 342
2022
Q3
$0 Hold
21
﹤0.01% 435
2022
Q2
$1K Buy
+21
New +$603 ﹤0.01% 400
2016
Q4
Sell
-9,414
Closed -$326K 260
2016
Q3
$326K Sell
9,414
-205
-2% -$7.18K 0.05% 112
2016
Q2
$313K Sell
9,619
-251
-3% -$7.69K 0.05% 110
2016
Q1
$283K Sell
9,870
-682
-6% -$18.2K 0.05% 97
2015
Q4
$353K Sell
10,552
-323
-3% -$10K 0.06% 91
2015
Q3
$309K Sell
10,875
-96
-0.9% -$3.35K 0.06% 89
2015
Q2
$445K Sell
10,971
-478
-4% -$21.5K 0.08% 89
2015
Q1
$563K Sell
11,449
-165
-1% -$7.64K 0.1% 88
2014
Q4
$529K Buy
+11,614
New +$456K 0.09% 91

Other funds holding AVNS

Valley Wealth Managers's AVNS Position: Q4 2023 in Review

Valley Wealth Managers sold out of Avanos Medical (AVNS) in Q4 2023, closing a stake of 21 shares — an estimated $425 sold.

Valley Wealth Managers first reported a position in AVNS in Q4 2014 and held it in 14 quarters. The position peaked at $563K in Q1 2015. 265 funds tracked by Wall St. Rank hold AVNS as of Q4 2023.

  • Valley Wealth Managers reported no remaining Avanos Medical position as of Q4 2023 after selling out during the quarter.
  • Valley Wealth Managers sold 21 Avanos Medical shares in Q4 2023, an estimated $425.
  • Valley Wealth Managers first reported a position in Avanos Medical in Q4 2014 and held it in 14 quarters.
  • Valley Wealth Managers's Avanos Medical position peaked at $563K in Q1 2015.
  • 265 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2023.

Based on Valley Wealth Managers's 13F filing for Q4 2023, filed 7 Feb 2024.